HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

Antigen presentation by tumor cells in the context of Human Leukocyte Antigen (HLA) is generally considered to be a prerequisite for effective immune checkpoint inhibitor therapy. We evaluated cell surface HLA class I, HLA class II and cytoplasmic HLA-DM staining by immunohistochemistry (IHC) in 389...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijland, Marcel, Veenstra, Rianne N., Visser, Lydia, Xu, Chuanhui, Kushekhar, Kushi, van Imhoff, Gustaaf W., Kluin, Philip M., van den Berg, Anke, Diepstra, Arjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414870/
https://www.ncbi.nlm.nih.gov/pubmed/28507804
http://dx.doi.org/10.1080/2162402X.2017.1295202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414870/
https://www.ncbi.nlm.nih.gov/pubmed/28507804
http://dx.doi.org/10.1080/2162402X.2017.1295202

Ejemplares similares